MedTrace Logo

Screening for Advanced Heart Failure Treatment (SEE-HF)

NCT01626404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2022-06-24

No results posted yet for this study

Summary

Advanced heart failure therapy (heart transplantation or LVAD) is underutilized and patients are underserved. The purpose of this prospective, observational study is to obtain multi-center data on the proportion of patients with CRT and/or ICD who are candidates for advanced heart failure treatment and obtain insights into patient and physician decisions regarding referral for advanced heart failure therapy.

Conditions

  • Advanced Heart Failure
  • CRT and/or ICD

Sponsors & Collaborators

  • Thoratec Europe Ltd

    collaborator INDUSTRY

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Pooja Chatterjee · Thoratec Europe Limited

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Denmark
  • France
  • Germany
  • Netherlands
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01626404 on ClinicalTrials.gov